These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22048228)

  • 21. Is there a need for a universal benefit-risk assessment framework for medicines? Regulatory and industry perspectives.
    Leong J; McAuslane N; Walker S; Salek S
    Pharmacoepidemiol Drug Saf; 2013 Sep; 22(9):1004-12. PubMed ID: 23740622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How the elderly and young adults differ in the decision making process of nonprescription medication purchases.
    Sansgiry SS; Cady PS
    Health Mark Q; 1996; 14(1):3-21. PubMed ID: 10163023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Images of American sexuality in debates over nonprescription access to emergency contraceptive pills.
    Wynn LL; Trussell J
    Obstet Gynecol; 2006 Nov; 108(5):1272-6. PubMed ID: 17077255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prescription and nonprescription drug use among at-risk community-dwelling seniors in Ottawa-Carleton.
    Walop W; Amos S; Dalziel W; Dunkley G; Jaouich R; Strachan N; Lamont C
    Can J Clin Pharmacol; 1999; 6(2):93-100. PubMed ID: 10519735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR
    Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of the BRAT framework to case studies: observations and insights.
    Levitan BS; Andrews EB; Gilsenan A; Ferguson J; Noel RA; Coplan PM; Mussen F
    Clin Pharmacol Ther; 2011 Feb; 89(2):217-24. PubMed ID: 21178990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consumers' perceptions about risk of and access to nonprescription medications.
    Alexander GC; Mohajir N; Meltzer DO
    J Am Pharm Assoc (2003); 2005; 45(3):363-70. PubMed ID: 15991758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Over-the-counter analgesics and antipyretics: a critical assessment.
    Hersh EV; Moore PA; Ross GL
    Clin Ther; 2000 May; 22(5):500-48. PubMed ID: 10868553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Food and Drug Administration risk evaluation and mitigation strategy.
    Craig DS
    J Pain Palliat Care Pharmacother; 2010 Jun; 24(2):145-8. PubMed ID: 20504137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The assessment of risks, benefits and availability of non-narcotic analgesics. A commonsense approach.
    Darmansjah I
    Med Toxicol; 1986; 1 Suppl 1():115-20. PubMed ID: 3821425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of advances in technology for maritime risk assessment.
    Wang J; Sii HS; Yang JB; Pillay A; Yu D; Liu J; Maistralis E; A Saajedi
    Risk Anal; 2004 Aug; 24(4):1041-63. PubMed ID: 15357827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonprescription drug use among the elderly.
    Johnson RE; Pope CR
    Am J Prev Med; 1985; 1(3):41-6. PubMed ID: 3870904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An integrated approach to data management, risk assessment, and decision making.
    Till JE; Grogan HA; Mohler HJ; Rocco JR; Rood AS; Mohler SS
    Health Phys; 2012 Apr; 102(4):367-77. PubMed ID: 22378197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonprescription drugs and the elderly.
    Lamy PP
    Am Fam Physician; 1989 Jun; 39(6):175-9. PubMed ID: 2729042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integration of environmental and human health risk assessment for industries using hazardous materials: a quantitative multi criteria approach for environmental decision makers.
    Topuz E; Talinli I; Aydin E
    Environ Int; 2011 Feb; 37(2):393-403. PubMed ID: 21111481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are non-prescription medications needed for weight control?
    Bray GA
    Obesity (Silver Spring); 2008 Mar; 16(3):509-14. PubMed ID: 18239604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New meds, new concerns.
    Brooks R
    Occup Health Saf; 2003 Apr; 72(4):28-30, 32. PubMed ID: 12710277
    [No Abstract]   [Full Text] [Related]  

  • 38. Enhancing the credibility of decisions based on scientific conclusions: transparency is imperative.
    Schreider J; Barrow C; Birchfield N; Dearfield K; Devlin D; Henry S; Kramer M; Schappelle S; Solomon K; Weed DL; Embry MR
    Toxicol Sci; 2010 Jul; 116(1):5-7. PubMed ID: 20363830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of consumers' perceptions of drugs to drug use.
    Grahn JL
    Public Health Rep; 1983; 98(1):85-90. PubMed ID: 6828642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implications of the reclassification of drugs from prescription-only to over-the-counter status.
    Gossel TA
    Clin Ther; 1991; 13(2):200-15; discussion 199. PubMed ID: 1863936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.